Ventana Rejects Roche Acquisition Offer Again as Discussions Continue | GenomeWeb
NEW YORK (GenomeWeb News) – Ventana Medical Systems has urged its shareholders again to reject Roche’s extended offer to buy the firm for $75 per share.
The offer marks the fifth time that Roche has sought to get approval from Ventana’s shareholders to acquire the firm for $75 per share, or roughly $3 billion. Ventana’s stock closed yesterday at $86.07 on the Nasdaq.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.